Abstract

Germ line mutations in ETV6 are responsible for a familial thrombocytopenia and leukemia predisposition syndrome. Thrombocytopenia is almost completely penetrant and is usually mild. Leukemia is reported in ∼30% of carriers and is most often B-cell acute lymphoblastic leukemia. The mechanisms by which ETV6 dysfunction promotes thrombocytopenia and leukemia remain unclear. Care for individuals with ETV6-related thrombocytopenia and leukemia predisposition includes genetic counseling, treatment or prevention of excessive bleeding and surveillance for the development of hematologic malignancy.

Original languageEnglish
Pages (from-to)663-667
Number of pages5
JournalBlood
Volume134
Issue number8
DOIs
StatePublished - Aug 22 2019

Fingerprint

Dive into the research topics of 'ETV6-related thrombocytopenia and leukemia predisposition'. Together they form a unique fingerprint.

Cite this